Telomerase as a tumor-associated antigen for cancer immunotherapy
- 1 June 2004
- journal article
- Published by Springer Science and Business Media LLC in Cytotechnology
- Vol. 45 (1-2), 91-99
- https://doi.org/10.1007/s10616-004-5132-2
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T LymphocytesClinical Cancer Research, 2004
- Telomerase Maintains Telomere Structure in Normal Human CellsCell, 2003
- CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytesNature, 2003
- From cancer genomics to cancer immunotherapy: toward second-generation tumor antigensTrends in Immunology, 2001
- Identification of human telomerase reverse transcriptase–derived peptides that induce HLA-A24–restricted antileukemia cytotoxic T lymphocytesBlood, 2001
- Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomeraseOncogene, 1998
- Extension of Life-Span by Introduction of Telomerase into Normal Human CellsScience, 1998
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Genes Coding for Tumor Antigens Recognized by Cytolytic T LymphocytesImmunological Reviews, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994